Bath & Body Works (NYSE:BBWI) Releases Q3 2026 Earnings Guidance

Key Points

• Bath & Body Works guided Q3 2026 EPS to $0.07–$0.12, well below the $0.27 analyst consensus, while revenue guidance of $1.6–$1.7 billion is broadly in line with expectations. Full-year 2026 EPS guidance was set at $2.60–$2.80.
• The company’s latest quarter beat estimates with EPS of $0.32 and revenue of $1.38 billion, but revenue declined 3.2% year over year and EPS fell from $0.49 in the prior-year quarter.
• Bath & Body Works declared a quarterly dividend of $0.20 per share, or $0.80 annualized, representing a 4.6% yield. Analysts maintain a consensus “Hold” rating with an average price target of $22.57.

Bath & Body Works (NYSE:BBWI - Get Free Report) issued an update on its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.070-0.120 for the period, compared to the consensus earnings per share estimate of 0.270. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion. Bath & Body Works also updated its FY 2026 guidance to 2.600-2.800 EPS.

Bath & Body Works Stock Performance

BBWI opened at $17.58 on Wednesday. The company has a fifty day moving average of $20.39 and a two-hundred day moving average of $20.03. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The stock has a market capitalization of $3.54 billion, a price-to-earnings ratio of 4.94, a PEG ratio of 1.89 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the previous year, the business earned $0.49 EPS. Bath & Body Works's revenue for the quarter was down 3.2% compared to the same quarter last year. On average, equities research analysts forecast that Bath & Body Works will post 2.63 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.6%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works's payout ratio is 22.47%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on BBWI shares. Weiss Ratings upgraded shares of Bath & Body Works from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Thursday, July 9th. JPMorgan Chase & Co. lifted their price target on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a "neutral" rating in a research report on Tuesday, August 18th. UBS Group reaffirmed a "neutral" rating on shares of Bath & Body Works in a research report on Wednesday, August 19th. Jefferies Financial Group boosted their target price on Bath & Body Works from $22.00 to $23.00 and gave the company a "hold" rating in a research report on Tuesday, July 28th. Finally, Barclays reduced their price target on shares of Bath & Body Works from $25.00 to $23.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 28th. Four investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $22.57.

Institutional Trading of Bath & Body Works

A number of institutional investors have recently bought and sold shares of BBWI. Global Retirement Partners LLC acquired a new position in Bath & Body Works during the fourth quarter worth approximately $31,000. Geneos Wealth Management Inc. grew its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after acquiring an additional 801 shares during the last quarter. Parallel Advisors LLC grew its position in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company's stock worth $38,000 after acquiring an additional 567 shares during the last quarter. Danske Bank A S acquired a new position in shares of Bath & Body Works in the 3rd quarter valued at $39,000. Finally, Advisory Services Network LLC purchased a new stake in Bath & Body Works in the 3rd quarter valued at $48,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source